Furthermore, we also show that genetic and pharmacological inhibition of C5aR1 signalling decrease cancer cell survival under hypoxic conditions, with strategies able to inhibit intracellular C5aR1 pools showing the greatest effects on survival. The gene discussed is C5AR1; the disease is cancer.